| Literature DB >> 32130898 |
Valentin Sencio1, Adeline Barthelemy1, Luciana P Tavares2, Marina G Machado3, Daphnée Soulard1, Céline Cuinat4, Celso Martins Queiroz-Junior2, Marie-Louise Noordine4, Sophie Salomé-Desnoulez1, Lucie Deryuter1, Benoit Foligné5, Céline Wahl6, Benoit Frisch7, Angelica T Vieira2, Christophe Paget1, Graeme Milligan8, Trond Ulven9, Isabelle Wolowczuk1, Christelle Faveeuw1, Ronan Le Goffic10, Muriel Thomas4, Stéphanie Ferreira6, Mauro M Teixeira2, François Trottein11.
Abstract
Secondary bacterial infections often complicate viral respiratory infections. We hypothesize that perturbation of the gut microbiota during influenza A virus (IAV) infection might favor respiratory bacterial superinfection. Sublethal infection with influenza transiently alters the composition and fermentative activity of the gut microbiota in mice. These changes are attributed in part to reduced food consumption. Fecal transfer experiments demonstrate that the IAV-conditioned microbiota compromises lung defenses against pneumococcal infection. In mechanistic terms, reduced production of the predominant short-chain fatty acid (SCFA) acetate affects the bactericidal activity of alveolar macrophages. Following treatment with acetate, mice colonized with the IAV-conditioned microbiota display reduced bacterial loads. In the context of influenza infection, acetate supplementation reduces, in a free fatty acid receptor 2 (FFAR2)-dependent manner, local and systemic bacterial loads. This translates into reduced lung pathology and improved survival rates of double-infected mice. Lastly, pharmacological activation of the SCFA receptor FFAR2 during influenza reduces bacterial superinfection.Entities:
Keywords: acetate; bacterial superinfection; food restriction; free fatty acid receptor 2; gut microbiota; influenza A virus; macrophages; microbial dysbiosis; short-chain fatty acid
Mesh:
Substances:
Year: 2020 PMID: 32130898 DOI: 10.1016/j.celrep.2020.02.013
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423